What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

BioCryst Pharmaceuticals BCRX Debt-to-equity

Discontinued — last reported Q3 '20

Debt-to-equity at other companies

Ionis PharmaceuticalsIONS

1.4×+1.1×

Ultragenyx PharmaceuticalRARE

3.7×—

Arrowhead ResearchARWR

0.2×0.0×

Agios PharmaceuticalsAGIO

0×0.0×

ALN

Alnylam PharmaceuticalsALNY

0.2×-0.4×

PrecigenPGEN

4.9×—

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Current ratio1.9×-1.0×

Where this comes from

Calculated from BioCryst Pharmaceuticals’s reported figures.

total debt/total stockholders equity=0.1×

Based on the most recent quarter.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed November 6, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.